Chemical Compound
1,8-Naphthyridine-3-carboxylic acid, 1-ethyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)- (9CI, ACI); 1-Ethyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-1,8-naphthyridine-3-carboxylic acid (ACI); 1-Ethyl-6-fluoro-4-oxo-7-(piperazin-1-yl)-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid; 1-Ethyl-6-fluoro-4-oxo-7-piperazin-4-ium-1-yl-1,8-naphthyridine-3-carboxylate; AT 2266; CI 919; Enofloxacin; Enofloxacine; Enoksetin; Enoxacine; ENOXOR; Flumark; MeSH ID: D015365; NSC 629661; PD 107779; Penetrex; Penetrex (pharmaceutical)
CAS Registry Number
74011-58-8
Primary record
1,8-Naphthyridine-3-carboxylic acid, 1-ethyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)- (9CI, ACI); 1-Ethyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-1,8-naphthyridine-3-carboxylic acid (ACI); 1-Ethyl-6-fluoro-4-oxo-7-(piperazin-1-yl)-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid; 1-Ethyl-6-fluoro-4-oxo-7-piperazin-4-ium-1-yl-1,8-naphthyridine-3-carboxylate; AT 2266; CI 919; Enofloxacin; Enofloxacine; Enoksetin; Enoxacine; ENOXOR; Flumark; MeSH ID: D015365; NSC 629661; PD 107779; Penetrex; Penetrex (pharmaceutical)
- 库存
- 7,336 克
- 纯度
- 99.0 %
- CAS
- 74011-58-8
化合物标识与属性
- CAS
- 74011-58-8
- PubChem CID
- 3229
- SMILES
- CCN1C=C(C(=O)C2=CC(=C(N=C21)N3CCNCC3)F)C(=O)O
- Canonical SMILES
- CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)nc21
名称与同义词
- enoxacin
- Penetrex
- Enoxacine
- Comprecin
- Flumark
- Enoxacino
- Enoxacinum
- Bactidan
- 74011-58-8
- Almitil
- Enoram
- Enoxor
- enofloxacin
- Enoksetin
- Enoxin
- Enofloxacine
- Bactidron
- Enroxil
- Enoxen
- Enoxacine [French]
- Enoxacinum [Latin]
- Enoxacin (Penetrex)
- Enoxacino [Spanish]
- Tariquidar
- Enoxacina
- Abenox
- Enoxacin Sesquihydrate
- AT-2266
- Penetrex (TN)
- Enoxacin (hydrate)
- Bactidron (TN)
- Comprecin (TN)
- Enoksetin (TN)
- Bactidan (TN)
- CI-919
- Prestwick_708
- Almitil (TN)
- Enroxil (TN)
- Flumark (TN)
- Gyramid (TN)
- Enoxen (TN)
- Enoxin (TN)
- Enoxor (TN)
- Vinone (TN)
- 1-Ethyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-1,8-naphthyridine-3-carboxylic acid
- Enoxacin (USAN/INN)
- C15H17FN4O3
- Sesquihydrate, Enoxacin
- Spectrum_001539
- CHEMBL826
- ENOXACIN [USAN]
- RefChem:57719
- ENOXACIN [INN]
- CI 919
- ENOXACIN [MI]
- PD 107779
- AC1L1FGQ
- ENOXACIN [VANDF]
- Prestwick0_000353
- Prestwick1_000353
- Prestwick2_000353
- Prestwick3_000353
- Spectrum2_001731
- Spectrum3_001570
- Spectrum4_000166
- Spectrum5_001044
- CCRIS 5242
- ENOXACIN [MART.]
- PD-107779
- DTXSID5022984
- D0R8ER
- ENOXACIN [WHO-DD]
- Epitope ID:119069
- Faulding Brand of Enoxacin
- UNII-I9CD31N8WB
- UNII-325OGW249P
- Enoxacin [USAN:BAN:INN:JAN]
- CHEBI:157175
- DTXCID002984
- IDYZIJYBMGIQMJ-UHFFFAOYSA-N
- 325OGW249P
- Oprea1_147866
- SCHEMBL33963
- BSPBio_000445
- BSPBio_003080
- Enoxacin, analytical standard
- KBioGR_000651
- KBioSS_002019
- MLS000069645
- MLS006011976
- BIDD:GT0191
- DivK1c_000420
- NSC 629661
- NSC-629661
- NSC-758416
- SPECTRUM1503215
- Enoxacin [USAN:INN:BAN:JAN]
- SPBio_001802
- SPBio_002366
- ENOXACIN [ORANGE BOOK]
- Enoxacin, 98% - 1g 1g
- MFCD00133308
- BPBio1_000491
- CI919
- GTPL8882
- orb1310354
- 4,6-DIMETHOXYPYRIMIDINE
- NSC 627409
- SCHEMBL29384458
- BCBcMAP01_000009
- CTK8E3243
- ERK5-2N12
- HMS501E22
- KBio1_000420
- KBio2_002019
- KBio2_004587
- KBio2_007155
- KBio3_002580
- 1-ethyl-6-fluoro-4-oxo-7-(piperazin-1-yl)-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid
- BRN 3628995
- CID3229
- J01MA04
- MSK5714
- 8-naphthyridine-3-carboxylic acid
- AT2266
- NINDS_000420
- NSC629661
- GLXC-06955
- HMS1569G07
- HMS1922I17
- HMS2090E10
- HMS2092N20
- HMS2233K20
- HMS3372A12
- HMS3655M08
- HMS3715H13
- HMS5080A03
- HMS5084L13
- Pharmakon1600-01503215
- 1-ethyl-6-fluoro-4-oxo-7-piperazin-1-yl-1,8-naphthyridine-3-carboxylic acid
- AT 2266
- AT 2266;CI 919
- BCP22623
- HY-B0268
- Tox21_110688
- BDBM50296358
- C15-H17-F-N4-O3
- CCG-39452
- EBC-00603
- MSK5714-100M
- NCGC00016927-01
- NSC758416
- s1756
- ZINC19594549
- PD107779
- AKOS015838626
- Tox21_110688_1
- CL23362
- CS-2257
- DB00467
- FE22673
- KS-5190
- NE58656
- 84294-96-2
- CAS-74011-58-8
- IDI1_000420
- SMP1_000113
- E0762
- NCGC00016927-02
- NCGC00016927-03
- NCGC00016927-04
- NCGC00016927-05
- NCGC00016927-06
- NCGC00016927-07
- NCGC00016927-08
- NCGC00016927-10
- NCGC00016927-11
- NCGC00023864-03
- NCGC00023864-04
- NCGC00178309-01
- NCGC00178309-02
- AN-37251
- Enoxacin Solution in Methanol, 100ug/mL
- J20.568K
- K259
- LS-95946
- NCI60_009618
- SC-13757
- SMR000058233
- ST044514
- SBI-0051788.P002
- AB0014125
- AB1011529
- DB-055829
- TL8005116
- TR-037960
- A8423
- FT-0630825
- NS00000506
- Pierre Fabre Brand of Enoxacin Sesquihydrate
- SW196857-3
- C06979
- D00310
- EN300-122627
- J10280
- 1, 6-fluoro-1,4-dihydro- 4-oxo-7-piperazinyl
- AB00052328-09
- AB00052328_10
- AB00052328_11
- 011E588
- A837996
- Enoxacin sesquihydrate;AT-2266 hydrate;CI-919 hydrate
- SR-01000000202
- I06-0290
- Q1639616
- Rhone Poulenc Rorer Brand of Enoxacin Sesquihydrate
- Rhone-Poulenc Rorer Brand of Enoxacin Sesquihydrate
- SR-01000000202-2
- SR-01000000202-3
- 1,8-Naphthyridine-3-carboxylic acid, 1,4-dihydro-1-ethyl-6-fluoro-4-oxo-7-(1-piperazinyl)-
- 1,8-Naphthyridine-3-carboxylic acid, 1-ethyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-
- 1-Ethyl-6-fluoro-4-oxo-7-piperazin-1-yl-1,4-dihydro-[1,8]naphthyridine-3-carboxylic acid
- BRD-K78113049-001-05-5
- BRD-K78113049-001-07-1
- BRD-K78113049-001-12-1
- BRD-K78113049-001-15-4
- BRD-K78113049-001-16-2
- BRD-K78113049-001-17-0
- Z1544404495
- 1-ethyl-6-fluoro-4-oxo-7-piperazin-1-yl-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid
- 1-Ethyl-6-fluoro-1,4-dihydro-4-oxo-7-[1-piperazinyl]-1,8-naphthyridine-3-carboxylic acid
- 1-ethyl-6-fluoro-4-oxo-7-piperazinylhydropyridino[2,3-b]pyridine-3-carboxylic acid
- 1,4-Dihydro-1-ethyl-6-fluoro-4-oxo-7-(1-piperazinyl)-1,8-naphthyridine-3-carboxylic acid
- 1,8-Naphthyridine-3-carboxylic acid, 6-fluoro-1,4-dihydro-4-oxo-7-piperazinyl
- 1-Ethyl-4-oxo-6-fluoro-7-(1-piperazinyl)-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid
- 1-Ethyl-4-oxo-6-fluoro-7-piperazino-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid
- 1-Ethyl-6-fluoro-1,4-dihydro-4-oxo-7- [1-piperazinyl]-1,8-naphthyridine-3-carboxylic acid
- 1-Ethyl-6-fluoro-1,4-dihydro-4-oxo-7-piperazino-1,8-naphthyridine-3-carboxylic acid
- 1-Ethyl-6-fluoro-4-oxo-7-(1-piperazinyl)-1,4-dihydro[1,8]naphthyridine-3-carboxylic acid
- 1-Ethyl-6-fluoro-4-oxo-7-piperazin-1-yl-1,4-dihydro-(1,8)naphthyridine-3-carboxylic acid
- 1-Ethyl-6-fluoro-4-oxo-7-piperazin-1-yl-1,4-dihydro-quinoline-3-carboxylic acid
- 1-Ethyl-6-fluoro-7-piperazino-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid
- 1,8-NAPHTHYRIDINE-3-CARBOXYLIC ACID, 1-ETHYL-6-FLUORO-1,4-DIHYDRO-4-OXO-7-(1-PIPERAZINYL)
- 1,8-Naphthyridine-3-carboxylic acid, 1-ethyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)- (9CI, ACI); 1-Ethyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-1,8-naphthyridine-3-carboxylic acid (ACI); 1-Ethyl-6-fluoro-4-oxo-7-(piperazin-1-yl)-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid; 1-Ethyl-6-fluoro-4-oxo-7-piperazin-4-ium-1-yl-1,8-naphthyridine-3-carboxylate; AT 2266; CI 919; Enofloxacin; Enofloxacine; Enoksetin; Enoxacine; ENOXOR; Flumark; MeSH ID: D015365; NSC 629661; PD 107779; Penetrex; Penetrex (pharmaceutical)
- 1,8-Naphthyridine-3-carboxylic acid, 1-ethyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-, hydrate (2:3)
- 206873-63-4
- 3-QUINOLINECARBOXAMIDE, N-[2-[[[4-[2-(3,4-DIHYDRO-6,7-DIMETHOXY-2(1H)-ISOQUINOLINYL)ETHYL]PHENYL]AMINO]CARBONYL]-4,5-DIMETHOXYPHENYL]-
- 961-175-5
- AT 2266; CI 919;Penetrex; Enoxacine; Comprecin; Enoxacino; PD 107779; PD-107779; PD107779